Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer
Sinn, BV, et al. Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer. Clinical Cancer Research February 16 2021. DOI: 10.1158/1078-0432.CCR-20-3113
Download pdf 922KB
View External Link
- Categories
- Abstracts